Therapy Areas: Allergy
14 February 2025 - Australian biotechnology company CSL (ASX:CSL; USOTC:CSLLY) announced on Thursday that it has received approval from the European Commission for ANDEMBRY (garadacimab), the first an...
30 January 2025 - Danish pharmaceutical company ALK-Abelló A/S (ALK) (CPH:ALK-B) announced on Thursday that the UK's National Institute for Health and Care Excellence (NICE) has recommende...
9 January 2025 - Swiss biopharmaceutical company Stallergenes Greer International AG announced on Thursday that the European Commission has approved the extension of Palforzia's indication to inc...
23 December 2024 - US-based pharmaceutical company Eli Lilly and Co announced on Friday that it has received approval from the US Food and Drug Administration for its Zepbound (tirzepatide) intended f...
16 December 2024 - Australia-based global biotechnology company CSL (ASX:CSL) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended m...
5 December 2024 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Thursday the launch of a Phase 3 clinical trial to evaluate LAGEVRIO (mo...